Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.
2.

Letter by Stone et al regarding article, "perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals".

Stone NJ, Lloyd-Jones DM, Blum C, Goff DC Jr, Smith SC Jr.

Circ Res. 2014 Jun 20;115(1):e1-2. doi: 10.1161/CIRCRESAHA.114.303996. No abstract available.

3.
4.

Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.

Yeboah J, Polonsky TS, Young R, McClelland RL, Delaney JC, Dawood F, Blaha MJ, Miedema MD, Sibley CT, Carr JJ, Burke GL, Goff DC Jr, Psaty BM, Greenland P, Herrington DM.

Circulation. 2015 Sep 8;132(10):916-22. doi: 10.1161/CIRCULATIONAHA.115.016846. Epub 2015 Jul 29.

5.

The 2013 ACC/AHA guidelines on the treatment of blood cholesterol: questions, questions, questions.

Ginsberg HN.

Circ Res. 2014 Feb 28;114(5):761-4. doi: 10.1161/CIRCRESAHA.114.303398. No abstract available.

6.

Cholesterol treatment and changes in guidelines in an academic medical practice.

Schoen MW, Salas J, Scherrer JF, Buckhold FR.

Am J Med. 2015 Apr;128(4):403-9. doi: 10.1016/j.amjmed.2014.10.039. Epub 2014 Nov 18.

PMID:
25460526
7.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines..

J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12. No abstract available. Erratum in: J Am Coll Cardiol. 2015 Dec 22;66(24):2812. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):3024-3025.

8.

A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.

Karmali KN, Goff DC Jr, Ning H, Lloyd-Jones DM.

J Am Coll Cardiol. 2014 Sep 9;64(10):959-68. doi: 10.1016/j.jacc.2014.06.1186.

10.
11.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines..

Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a. Epub 2013 Nov 12. No abstract available. Erratum in: Circulation. 2015 Dec 22;132(25):e396. Circulation. 2014 Jun 24;129(25 Suppl 2):S46-8.

12.

Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.

Bruckert E, Ferrières J.

Arch Cardiovasc Dis. 2014 Mar;107(3):188-200. doi: 10.1016/j.acvd.2014.01.011. Epub 2014 Mar 7.

13.

A new way to get heart-healthy. Recently released guidelines could change the way women are treated with statin drugs.

[No authors listed]

Harv Womens Health Watch. 2014 Apr;21(8):3. No abstract available.

PMID:
25097940
14.

2013 ACC/AHA guideline on the treatment of blood cholesterol: a fresh interpretation of old evidence.

Psaty BM, Weiss NS.

JAMA. 2014 Feb 5;311(5):461-2. doi: 10.1001/jama.2013.284203. No abstract available.

PMID:
24264722
15.

Primary prevention of atherosclerotic cardiovascular disease: controversies and clinical considerations.

Newsom LC.

Ann Pharmacother. 2015 Apr;49(4):484-93. doi: 10.1177/1060028014564181. Epub 2014 Dec 19. Review.

PMID:
25527102
16.

Merits and potential downsides of the 2013 ACC/AHA cholesterol management guidelines.

Gotto AM, Moon JE.

Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):573-6. doi: 10.1016/j.numecd.2014.04.002. Epub 2014 Apr 18.

PMID:
24819819
17.

2013 ACC/AHA cholesterol treatment guideline: what was done well and what could be done better.

Martin SS, Abd TT, Jones SR, Michos ED, Blumenthal RS, Blaha MJ.

J Am Coll Cardiol. 2014 Jun 24;63(24):2674-8. doi: 10.1016/j.jacc.2014.02.578. Epub 2014 Mar 26. Review.

18.

Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline.

Pokharel Y, Steinberg L, Chan W, Akeroyd JM, Jones PH, Nambi V, Nasir K, Petersen L, Ballantyne CM, Virani SS.

Atherosclerosis. 2016 Mar;246:115-20. doi: 10.1016/j.atherosclerosis.2015.12.044. Epub 2016 Jan 6.

PMID:
26773472
19.

What is the role of the clinical laboratory in the new ACC/AHA guidelines for the treatment of blood cholesterol in adults?

Jialal I.

Am J Clin Pathol. 2014 Jun;141(6):772-3. doi: 10.1309/AJCPED9X7RNMYAEQ. No abstract available.

PMID:
24838319
20.

Supplemental Content

Support Center